Cargando…

Is it time to revise the International Association for the Study of Lung Cancer definitions of completeness of lung cancer resection?

Detalles Bibliográficos
Autores principales:	Rami-Porta, Ramón, Edwards, John G., Osarogiagbon, Raymond U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834576/ https://www.ncbi.nlm.nih.gov/pubmed/36644172 http://dx.doi.org/10.21037/tcr-22-2426

Ejemplares similares

The Evolving Concept of Complete Resection in Lung Cancer Surgery
por: Rami-Porta, Ramón
Publicado: (2021)

Prehabilitation in lung cancer resection—are we any closer to the ideal program?
por: Mahendran, Kajan, et al.
Publicado: (2020)

Postoperative Radiotherapy in Completely Resected IIIA-N2 Non-small Cell Lung Cancer: Quit or Not?
por: Chen, Yu, et al.
Publicado: (2023)

Commentary: Lung cancer resections during the pandemic
por: Shenoy, Rohit, et al.
Publicado: (2022)

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

Limited-anatomic resection for ground-glass like lung cancer—simplicity does not mean inefficacy
por: Li, Qiuyuan, et al.
Publicado: (2022)

Adjuvant osimertinib for resected EGFR-mutated non-small cell lung cancer: a game-changer?
por: Patel, Shruti R., et al.
Publicado: (2023)

Future Perspectives on the TNM Staging for Lung Cancer
por: Rami-Porta, Ramón
Publicado: (2021)

Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold!
por: Fiorelli, Alfonso, et al.
Publicado: (2020)

Revisions to the IASP definition of pain—What does this mean for children?
por: Stevens, Bonnie
Publicado: (2021)

Impact of a Lymph Node Specimen Collection Kit on the Distribution and Survival Implications of the Proposed Revised Lung Cancer Residual Disease Classification: A Propensity-Matched Analysis
por: Smeltzer, Matthew P., et al.
Publicado: (2021)

Expression Profiles and Clinicopathologic Features in Early Resected Non-small-cell Lung Cancer()
por: Rosell, Rafael
Publicado: (2014)

Prognostic value of epigenomic profiling in lung cancer
por: Mishra, Alok, et al.
Publicado: (2019)

Lung cancer in India: Current status and promising strategies
por: Parikh, P. M., et al.
Publicado: (2016)

Clinical applications of DNA methylation profiling in lung cancer
por: Castro-Gonzalez, Sergio, et al.
Publicado: (2023)

The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: Definition
por: Soweid, Assaad M.
Publicado: (2017)

A proposal for a postoperative protocol for the early diagnosis of bronchopleural fistula after lung resection surgery
por: Bertolaccini, Luca, et al.
Publicado: (2021)

Resectable non-small cell lung cancer: an evolving landscape
por: Loh, Jerold, et al.
Publicado: (2022)

The extent of pulmonary resection for lung metastases from colorectal cancer
por: Mishima, Shuji, et al.
Publicado: (2022)

Patient-reported outcome measures in definitive chemoradiation for non-small cell lung cancer
por: Voong, Khinh Ranh, et al.
Publicado: (2020)

Perifissural nodules: ready for application into lung cancer CT screening?
por: Schreuder, Anton, et al.
Publicado: (2020)

Surgery for stage IV non-small cell lung cancer?
por: Puig, Carlos A., et al.
Publicado: (2020)

Surgery for early-stage small cell lung cancer: is it worth it?
por: Vyfhuis, Melissa A. L., et al.
Publicado: (2019)

Challenges of predicting immune checkpoint therapy responders in lung cancer
por: Marwitz, Sebastian
Publicado: (2019)

New potential targeted strategies in small cell lung cancer
por: de Toro, María, et al.
Publicado: (2023)

Commentary: Preserving lung with resection and reconstruction of the secondary carina
por: Weksler, Benny
Publicado: (2021)

Extravascular lung water and the pulmonary vascular permeability index may improve the definition of ARDS
por: Perel, Azriel
Publicado: (2013)

Cervical mediastinoscopy and video-assisted mediastinoscopic lymphadenectomy for the staging of non-small cell lung cancer
por: Call, Sergi, et al.
Publicado: (2019)

Adjuvant TKI therapy in resected EGFR-mutant non-small-cell lung cancer—ready for prime time?
por: Arulananda, Surein, et al.
Publicado: (2020)

Met in lung cancer
por: Dent, Paul
Publicado: (2014)

Druggable Drivers of Lung Cancer
por: Fawdar, Shameem, et al.
Publicado: (2013)

Different perspectives and viewpoints on the postoperative management of EGFR-mutant lung cancer
por: Nakao, Masayuki, et al.
Publicado: (2020)

EGFR and non-small cell lung cancer: implications for surgical practice
por: Varela, Gonzalo, et al.
Publicado: (2020)

Thoracoscopic anatomical segmentectomies for early-stage lung cancer: the coming challenge
por: Gossot, Dominique, et al.
Publicado: (2020)

Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2018)

Commentary: Patient frailty also drives long-term outcomes after R0 resection for lung cancer
por: Zambetti, Benjamin R., et al.
Publicado: (2021)

New method for discrimination of multiple primary lung cancer and metastatic lung cancer
por: Shen, Cheng, et al.
Publicado: (2022)

LADA: Time for a New Definition
por: Redondo, Maria J.
Publicado: (2013)

Sublobar Resection for Early-Stage Lung Cancer: An Oncologically Valid Procedure?
por: Diebels, Ian, et al.
Publicado: (2023)

Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_varuepipui6s317au4huig119j